Product Information

NEBIVOLOL 5 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1184 per EA under NDC 31722058690. Its NADAC has been published 262 times since Nov 17, 2021.

FDA first approved this application on Nov 3, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NEBIVOLOL 5 MG TABLET

Nebivolol
$0.1184per EA

Strength

5 mg/1

NDC

31722058690

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NEBIVOLOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203825

FDA Approved

11/3/2020

TE Code

AB

On Market Since

9/17/2021

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for NEBIVOLOL 5 MG TABLET has been published 262 times since Nov 17, 2021, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1184 per EA
All-time high$0.5746 (Dec 15, 2021)
All-time low$0.0878 (Jul 17, 2024)
52-week high$0.1184
52-week low$0.0974
Median price$0.1232
Average price$0.1974
Largest weekly change+36.9% (Aug 21, 2024)
Weeks tracked262
Tracking sinceNov 17, 2021

Price History

1W

+2.7%

1M

+4.5%

3M

+5.8%

6M

+17.3%

1Y

+8.6%

3Y

-36.6%

5Y

-79.4%

All

-79.4%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NEBIVOLOL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NEBIVOLOL 5 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1184 per EA (NDC 31722058690), effective Nov 18, 2026.

How has the price of NEBIVOLOL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for NEBIVOLOL 5 MG TABLET has declined 79.4%. It has been tracked across 262 weekly CMS publications since Nov 17, 2021.

What are the highest and lowest recorded NADAC prices for NEBIVOLOL 5 MG TABLET?

Since Nov 17, 2021, the NADAC for NEBIVOLOL 5 MG TABLET has ranged from a low of $0.0878 (Jul 17, 2024) to a high of $0.5746 (Dec 15, 2021), with a median of $0.1232 per EA.

Are there cheaper alternatives to NEBIVOLOL 5 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NEBIVOLOL 5 MG TABLET, is $0.1036 per EA — about 13% below NEBIVOLOL 5 MG TABLET.

Who manufactures NEBIVOLOL 5 MG TABLET?

NEBIVOLOL 5 MG TABLET (NDC 31722058690) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.